The main objective of the current study was to formulate poorly water soluble drug Spirinolactone by using solid dispersion technique in order to achieve a better dissolution rate which would further help in enhancing oral bioavailability. Solid dispersions were prepared using two methods; solvent method and fusion method. Solid dispersion was prepared by using polymers, such as Hydroxy propylymethyl cellulose (HPMC 6cp), Hydroxy propyl cellulose (HPC), Sodium carboxymethylcellulose (Na-CMC), Povidone K12, Povidone K30, Poloxamer 407. Solid dispersions containing Spironolactone with HPC (96.81%), HPMC 6cp (93.05%), Poloxamer 407 (90.84%) and Na-CMC (89.93%) provided higher release rate than the release rate of solid dispersion containing only Spironolactone (35.27%), and Spironolactone with Povidone K12 (76.17%), Povidone K30 (67.92%). So the present study revealed that the solid dispersion may be an ideal means of drug delivery system for poorly water soluble drugs. Further study in this field was required to establish these drug delivery systems so that in future it can be used effectively in commercial basis.
INTRODUCTION
Orally administered drugs completely absorb only when they show fair solubility in gastric medium and such drugs shows good bioavailability. Recently more than 40% NCEs (new chemical entities) developed in Pharmaceutical Industry are practically insoluble in water. These poorly water soluble drugs are allied with slow drug absorption leading to inadequate and variable bioavailability and gastrointestinal mucosal toxicity (Murray et al., 1997) .
Oral bioavailability of a drug depends on its solubility and/or dissolution rate, and dissolution may be the rate determining step for the onset of therapeutic activity. Solid dispersion, which was introduced in the early 1970s, is essentially a multi-component system, having drug dispersed in and around hydrophilic carrier(s). In order to improve the solubility and bioavailability of poorly water soluble drugs many methods are used. The solid dispersion approach has been widely used for improvement solubility, dissolution rate and hence bioavailability. Solid dispersion (SD) is one of such methods and it involves a dispersion of one or more active ingredients in an inert carrier or matrix in solid state prepared by melting, dissolution in solvent or melting-solvent method (Chiou and Riegelman, 1971) . The technique has been used for a wide variety of poorly aqueous soluble drugs such as nimesulide (Babu et al., 2003) , ketoprofen (Rogers and Anderson, 1982) , tenoxicam (El-Gazayerly, 2000) , nifedipine (Vippagunta et al., 2002) , nimodipine (Babu et al., 2002) . SD technology has been successfully been used for improving the solubility of the drugs and hence bioavailability, e.g., tenoxicam, tacrolimus (Yamashita et al., 2003) , indomethacin (Makiko et al., 2005) , ibuprofen (Loganathanat al., 2000) , nilvadipine (Hirasawa et al., 2009 ).
Therefore, the improvement of drug solubility thereby its oral bio-availability remains one of most challenging aspects of drug development process especially for oral drug delivery system. There are numerous approaches available and reported in literature to enhance the solubility of poorly water soluble drug. The techniques are chosen on the basis of certain aspects such as properties of drug under consideration, nature of excipients to be selected and nature of intended dosage form. This present work is intended to discuss the various traditional and novel techniques for solubility enhancement of hydrophobic drugs for oral pharmaceutical formulation (Boles Ponto and Schoenwald, 1990; Ozdmir and Ordu, 1998) . 
MATERIALS AND METHODS

Materials
METHOD
Preparation of Solid Dispersion by Solvent Method
At first Spironolactone (500 mg) was weighed accurately in an analytical balance and taken into dry and clean glass vials. Then Acetone (5 ml) was added (Patel MM and Patel DM, 2006) on each vial. Then each polymer (500 mg) was dissolved in the solvent using a vortex mixer to make a polymer solution (Table 1) . Drug, polymer and solvent combination was dried by using hair dryer until solid dispersion was formed. The solvent 
Preparation of Solid Dispersion by Fusion Method
At first 500 mg of the model drug, Spironolactone was accurately weighted and taken in glass vials and 5 ml Acetone was added as solvent to dissolve each vial and heated on a water bath containing paraffin liquid to melt the ingredients at the temperature of 120 o C. At this time, stirring was performed to make sure a homogenous mixing of the drug in the solvent. When the drug was completely dissolved in the solvent, then 500 mg of each polymer (HPMC 6cps, HPC, NaCMC, Povidone K12, Povidone K30, Poloxamer 407) were weighed accurately and mixed with the solution containing drug and solvent (Table 2) . Drug, polymer and solvent combination was cooled with constant stirring to homogeneously disperse the drug throughout the matrix.
Finally the formulations were withdrawn from vials, crushed in mortar and pestle, passed through 150 micron sieve. Then the resulted samples were weighed and transferred in fresh vials with proper labeling and its double amount of lactose was added as adsorbent on each vials. After mixing well the formulations were kept in desiccators until the dissolution started.
In vitro dissolution study of Solid Dispersion
In-vitro dissolution was carried out in a USP XXX apparatus 2 (Paddle Apparatus) in 900 ml of distilled water for 1 hour at 37±0.5ºC and at a rotational speed of 50 rpm. Dissolution samples were withdrawn at predetermined intervals and were filtered through 0.45 mm filters. The drug content was determined spectrophotometrically at lmax = 238 nm in the filtrate either directly or after appropriate dilution with the dissolution media. So it can be said that there was an appeal difference between the release rate of only Spironolactone and solid dispersion containing Spironolactone with different excipients. Solid dispersions containing Spironolactone with HPC, HPMC 6cp, Poloxamer 407 and NaCMC provided higher release rate than the release rate of solid dispersion containing only Spironolactone, Povidone K12, Povidone K30.
RESULT AND DISCUSSION
Effects of Spironolactone Solid dispersions using Different Concentrations of Poloxamers 407
Spironolactone solid dispersions were prepared by fusion method according to Table 3 and Table 4 respectively. It is difficult at this stage to explain in details the actual mechanism of release since, the polymer degradation starts during the dissolution period. However the possible reason of increased dissolution rate of Spironolactone was the use of carriers for which the wettability and spreadability of the precipitated drug occur by reducing aggregations in the readily soluble state.
CONCLUSION
In this experiment an attempt has been taken to evaluate Spironolactone release from the different polymer-drug loaded formulation of Solid dispersions. Observations of In-vitro dissolution of the solid dispersion of Spironolactone using distilled water as the media to study the drug release efficiency from the solid dispersion. These distorted solid dispersions may cause a wide variation in drug release pattern.
Spironolactone is a potassium-sparing diuretic, acts as a competitive antagonist to aldosterone. Spironolactone is poorly watersoluble drug and the present study was aimed to enhance the dissolution property of Spironolactone. So this study was endeavored to observe release pattern of drug from the solid dispersion of Spironolactone by using different polymers, such as HPMC 6cps, HPC, NaCMC, Povidone K12, Povidone K30, Poloxamer 407 The variables affecting drug dissolution was matrix property, hydrophilic excipients loading from the solid dispersion and also depend on the physicochemical property of the drug molecule. The major problem of poorly water soluble drugs especially for new molecules is bioavailability. Thus the main target is to increase the solubility of poorly water soluble drugs. So the present study reveals that solid dispersion may be an ideal means of drug delivery system for poorly water soluble drugs. Further study in this field is required to establish these drug delivery systems so that in future it can be used effectively in commercial basis.
